Test story -vigya - Clone2

A Data-Led Deep Dive Into The World’s Biggest Therapeutic Area

  
Generate a summary of this article
Listen to this article
Beta
test
Test (Shutterstock)

This examination of global market trends and the overall structure of the oncology sector sets the stage. Oncology is the pharmaceutical industry’s largest therapeutic area, representing about 18% of global prescription and over-the-counter sales in 2024. At roughly $220bn, the market is forecast to almost double by 2032, growing at 5-9% annually, according to Evaluate consensus forecasts (see Exhibit 1).

Oncology drugs not only account for a large amount of sales but also attract vast R&D investment. Over the last...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Growth

Oncology’s Next Decade: The Therapies And Players Reshaping A $400bn Future

 
• By Edwin Elmhirst and Lucie Ellis-Taitt

Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.

How To Decarbonize Pharma R&D

As the planet heats up and sea levels rise, the need to reduce carbon emissions is becoming ever more urgent. The life sciences industry is just one of many that are looking to cut the carbon it produces.

IV-Growth (Free-1): Jump-Start Your Exercise With This Mindset Reset

 
• By Nabil

A positive mindset can boost exercise motivation. Learn how mental shifts help you start—and stick with—a healthier fitness routine.

More from In Vivo

Clone Test Oncology’s Next Decade: The Therapies And Players Reshaping A $400bn Future - Clone

 
• By Edwin Elmhirst and Lucie Ellis-Taitt

Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.

In Vivo’s 2026 Rising Leaders-Part 1

 
• By Saba Afreen

The seventh annual edition of In Vivo’s Rising Leaders features entrepreneurs, academics, lawyers, regulators and innovators from around the globe, representing the forefront of creativity in health care.

XXXXtesting

 
• By Saba Afreen

XXXXtesting